The service will ensure best clinical intervention to improve outcomes in several chronic and generic kidney diseases including kidney transplants
CORE Diagnostics announced the launch of its division for advanced diagnostic services in nephrology called ‘nephroCORE.’ The service will ensure best clinical intervention to improve outcomes in several chronic and generic kidney diseases including kidney transplants.
CORE’s new addition of nephrology related diagnostic tests consists of advanced nephro-pathology services, molecular testing for rare and inherited (genetic) kidney diseases, screening for pre and post-transplant infectious diseases, monitoring drug levels, and Transplant Immunology.
CORE Diagnostics is also bringing ease to clinicians’ lives through real-time data collection done via easy shipping and doorstep sample collection using their special collection kits that offer better sample stability compared to the ones available in the market coupled with quality reporting and faster turnaround time.
On the occasion of the launch, Zoya Brar, Founder and MD, CORE Diagnostics said, “We want to bring back the focus on the unmet need to diagnose and treat kidney disease earlier in order to slow the progression of the disease. Unsuccessful or inadequate clinical intervention can impose a heavy financial burden on patients. Kidney disease is considered a silent disease; most cases are diagnosed in later stages. We are confident that with the newest addition of nephrology diagnostic services, we will improve the healthcare outcomes and quality of lives of the patients we serve.”
“Kidney biopsies are the gold-standard for the diagnosis of medical and transplant kidney disorders. At CORE, we run the rarest of high-end diagnostic markers on renal biopsy samples that help us come up with a definitive diagnosis along with prognostic information for the treating physician,” commented Dr Rajan Duggal, Vice President, nephro CORE.